Good Results
on Giving
uke received $264,424,566 in charitable gifts in the fiscal year that
ended June 30, with contributions from a record 89,852 donors, including
44,214 alumni, also a new high for the university. The total represents
the second-highest philanthropic giving in Duke’s history, after
the previous year’s record of $302,558,190.
“This represents another year of wonderful generosity
from a growing number of Duke alumni, parents, and friends,”
says President Nannerl O. Keohane. “Giving to the university
during the Campaign for Duke has allowed us to make steady and significant
progress in a host of crucial academic and student service areas,
and now also provides resources for the implementation of our strategic
plan. All members of our community are grateful to Duke donors, as
well as to our development volunteers and staff.”
Duke’s strategic plan, “Building on Excellence,”
was adopted by university trustees last February. Among other priorities,
it targets faculty support, strengthening science and engineering,
promoting diversity in the student body and staff, and expanding the
university’s reach locally, through such efforts as the university’s
Neighborhood Partnership Initiative, and globally.
The largest donor to Duke in the fiscal year just ended
was The Duke Endowment of Charlotte. The charitable trust created
by university founder James B. Duke gave more than $39 million for
a variety of purposes, including scholarships and academic programs.
The second-largest total came from Patty Wyngaarden Fitzpatrick ’69
and Michael J. Fitzpatrick ’70 of Hillsborough, California, who
gave $25 million each to Duke and Stanford universities to establish
new centers for advanced photonics, as well as more than $1 million
to Duke for its new football building.
University officials say the 2000-01 total reflects a
change in Duke’s reporting method. Until 2000-01, “clinical
trial” grant revenues, predominantly corporate contributions
that help fund some Duke Medical Center research on the effects of
a variety of diagnostic approaches and therapies, had an element in
the annual total of private gift and grant income. In 1999-2000, Duke
included clinical trials in its private gift and grant income—as
it always had. The clinical-trial total that year was $105.4 million;
last year’s clinical-trials total was $78.5 million.
“In the year just ended and in the future, income
from trials will not be reported,” says Robert Shepard, Duke’s
vice president for university development. “In the past, there
has not been uniformity in reporting, and we believe that the Council
for Advancement and Support of Education will soon recommend that
institutions not report trial revenue. We have decided to stop doing
so now.”
The goal for the university’s fund-raising effort,
the Campaign for Duke, was raised by the board of trustees last December
from $1.5 billion to $2 billion. The campaign total had reached $1.519
billion by June 30 and Shepard says it remains on schedule toward
the $2 billion goal by the end of 2003. He also says clinical-trial
revenues have never been included in the Campaign for Duke.
|
